Cardiac Amyloidosis and the V142I Transthyretin Variant
What is the natural history and cardiovascular burden of the V142I transthyretin variant among US Black individuals who carry this variant? Senthil Selvaraj, MD, MS, MA, from Duke University, and Scott D. Solomon, MD, from Brigham and Women's Hospital, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.
Related Content:
Cardiovascular Burden of the V142I Transthyretin Variant
Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger
Heart Failure in African American Individuals, Version 2.0
Cardiac Amyloidosis Due to Transthyretin…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.